SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Pastimes : Clown-Free Zone... sorry, no clowns allowed
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: mishedlo who wrote (180538)7/16/2002 10:40:17 PM
From: Archie Meeties  Read Replies (1) of 436258
 
Mish,

I've been on that same train of thought for a while now. Many of the small-mid cap techs continue to grow earnings even in this punk environment and some glean over 50% of revenue overseas, and will benefit in more way than one from the readjustment in our currency. How they could get cheaper? I guess they could trade at cash value, and some do.

Maybe we have 2 more years of a bear as measured by the S&P, but maybe it's over in small cap tech this year and mid cap tech next? Or maybe everything is just going to get incredibly cheap, like dirt.

BTW, there's a thread for biotechs trading under cash value if you want a speculative list to sort through. The list is long and keeps growing. Someone suggested that we instead make a thread containing only biotechs trading above cash value.

Subject 52724

There's about 10 of these with insider buying as well.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News